Entrepreneurship of Smart Medicines

Trinity College Dublin

Entrepreneurship of Smart Medicines

Course Overview
The M.Sc. in Entrepreneurship of Smart Medicines programme is designed to provide a new language to those coming from a non-biology background in drug discovery and pharmaceutical development. The course is also designed to provide a language of business and commercialisation to those knowledgeable in the area of biology. This course provides training in the area of drug development, biotech, pharma, and commercialisation.

Is This Course For Me?
This course will suit entrepreneurs, business sector specialists, and venture consultants and professionals looking to upskill in drug discovery and pharmaceutical development.

Course Structure
The Masters programme is worth 90 ECTS, comprised of 12 x 5 ECTS taught modules with an additional 30 ECTS research project. Students can choose to exit with a Postgraduate Diploma worth 60 ECTS created by the 12 5-ECTS taught modules without completing the research project.

Subjects taught

Students take the following modules: Biology for the Entrepreneur; Scientific Transformation of an Entrepreneur; Disease Indications & the Market I; Disease Indications & the Market II; Drug Development - The classics of large Pharma; Drug Development - Innovators and Disruptors: Clinical Development: Regulators and Manufacturers; Medical Devices & Biopharmaceuticals; Product & Company Licensing, Mergers & Valuations; Enterprise Development – Startups; Enterprise Development – IP and Leadership; and the Research Project.

Students will be full-time and complete all modules in one year.

The modules include:
Cellular Modules
• M01: Biology for the Entrepreneur
• M02: Scientific Transformation of an Entrepreneur

Disease Modules
• M03: Disease Indications & the Market I
• M04: Disease Indications & the Market II

Drug Development Modules
• M05: Drug Development - The classics of large Pharma
• M06: Drug Development - Innovators and Disruptors

Clinical Development Modules
• M07: Clinical Development
• M08: Regulators and Manufacturers
• M09: Medical Devices & Biopharmaceuticals

Pharmaceutical Commercialisation Modules
• M10: Product & Company Licensing, Mergers & Valuations
• M11: Enterprise Development – Start-ups
• M12: Enterprise Development – IP and Leadership

Research Project
• M13: Research Project (30 ECTS)

Entry requirements

Applicants will be expected to have an Honours Bachelor's degree at 2.1 (or above) in Science (such as cell biology, immunology, neuroscience, pharmacology, physiology), Health Sciences (such as medicine, nursing, allied health) or Business (including entrepreneurship, innovation, venture capital). Applicants with other primary degrees will also be considered. Other applicants without a primary degree may be considered by the Dean of Graduate Studies in exceptional circumstanced based on workplace experience.

Application dates

Closing Date: 31st July 2024.

Please click on "Application Weblink" above.


1 year full-time.

Enrolment dates

Next Intake: September 2024.

Post Course Info

Career Opportunities
Designed to bridge the gap between business and biology, this course trains, converts and upskills the "biologist-to-business" and "business-to-biologist", opening the door to careers in drug development, biotech, pharma and commercialisation.

More details
  • Qualification letters

    M.Sc./P.Grad.Dip exit only

  • Qualifications

    Degree - Masters (Level 9 NFQ)

  • Attendance type

    Full time,Daytime

  • Apply to

    Course provider